Cargando…

Lessons learned: from mentored to mentor

This Viewpoint was written in association with the 25th anniversary of the American Society for Clinical Investigation’s (ASCI’s) Stanley J. Korsmeyer Award, which honors the highest standards of scientific excellence, meritorious research, intellectual integrity, and the mentoring of future life-sc...

Descripción completa

Detalles Bibliográficos
Autor principal: Heitman, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843041/
https://www.ncbi.nlm.nih.gov/pubmed/36647823
http://dx.doi.org/10.1172/JCI167444
_version_ 1784870294769369088
author Heitman, Joseph
author_facet Heitman, Joseph
author_sort Heitman, Joseph
collection PubMed
description This Viewpoint was written in association with the 25th anniversary of the American Society for Clinical Investigation’s (ASCI’s) Stanley J. Korsmeyer Award, which honors the highest standards of scientific excellence, meritorious research, intellectual integrity, and the mentoring of future life-science researchers. In 2018, the award recognized Joseph Heitman (Figure 1), for his key contributions to our understanding of how eukaryotic microbial pathogens evolve, cause disease, and develop drug resistance and his discovery of TOR and FKBP12 as targets of the immunosuppressive chemotherapeutic drug rapamycin. Dr. Heitman has mentored numerous undergraduates, medical students, graduate students, and postdoctoral and medical fellows, many of whom have developed independent careers in medicine and basic biomedical research.
format Online
Article
Text
id pubmed-9843041
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-98430412023-01-20 Lessons learned: from mentored to mentor Heitman, Joseph J Clin Invest Viewpoint This Viewpoint was written in association with the 25th anniversary of the American Society for Clinical Investigation’s (ASCI’s) Stanley J. Korsmeyer Award, which honors the highest standards of scientific excellence, meritorious research, intellectual integrity, and the mentoring of future life-science researchers. In 2018, the award recognized Joseph Heitman (Figure 1), for his key contributions to our understanding of how eukaryotic microbial pathogens evolve, cause disease, and develop drug resistance and his discovery of TOR and FKBP12 as targets of the immunosuppressive chemotherapeutic drug rapamycin. Dr. Heitman has mentored numerous undergraduates, medical students, graduate students, and postdoctoral and medical fellows, many of whom have developed independent careers in medicine and basic biomedical research. American Society for Clinical Investigation 2023-01-17 /pmc/articles/PMC9843041/ /pubmed/36647823 http://dx.doi.org/10.1172/JCI167444 Text en © 2023 Heitman et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Viewpoint
Heitman, Joseph
Lessons learned: from mentored to mentor
title Lessons learned: from mentored to mentor
title_full Lessons learned: from mentored to mentor
title_fullStr Lessons learned: from mentored to mentor
title_full_unstemmed Lessons learned: from mentored to mentor
title_short Lessons learned: from mentored to mentor
title_sort lessons learned: from mentored to mentor
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843041/
https://www.ncbi.nlm.nih.gov/pubmed/36647823
http://dx.doi.org/10.1172/JCI167444
work_keys_str_mv AT heitmanjoseph lessonslearnedfrommentoredtomentor